CD137 Expression in Tumor Vessel Walls
Authors:
Open Access
- 1 April 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 115 (4) , 543-549
Abstract
CD137 (ILA/4-1BB), a member of the tumor necrosis factor receptor family, and its ligand are expressed on activated T lymphocytes and on antigen-presKeywords
This publication has 20 references indexed in Scilit:
- EXPRESSION OF SOLUBLE CD137 CORRELATES WITH ACTIVATION-INDUCED CELL DEATH OF LYMPHOCYTESCytokine, 2000
- CD137‐induced apoptosis is independent of CD95Immunology, 1999
- Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissueJournal of Leukocyte Biology, 1999
- Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lungEuropean Respiratory Journal, 1998
- Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumorsNature Medicine, 1997
- Moslecular and biological characterization of human 4‐1BB and its ligandsEuropean Journal of Immunology, 1994
- 4‐1BB T‐cell antigen binds to mature B cells and macrophages, and costimulates anti‐μ‐primed splenic B cellsEuropean Journal of Immunology, 1994
- A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor familyGene, 1993
- Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorEuropean Journal of Immunology, 1993
- cDNA sequences of two inducible T-cell genes.Proceedings of the National Academy of Sciences, 1989